Commentary: The pros and cons of essential medicines for rich countries

被引:3
作者
Reidenberg, MM
Walley, T
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7475期
关键词
D O I
10.1136/bmj.329.7475.1172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1172 / 1172
页数:1
相关论文
共 5 条
[1]  
*AUSTR GOV, PHARM BEN SCHEM EXP
[2]  
Bero LA, 1998, BMJ-BRIT MED J, V317, P465
[3]   The free trade agreement between Australia and the United States - Undermines Australian public health and protects US interests in pharmaceuticals [J].
Drahos, P ;
Henry, D .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7451) :1271-1272
[4]   The concept of essential medicines: lessons for rich countries [J].
Hogerzeil, HV .
BRITISH MEDICAL JOURNAL, 2004, 329 (7475) :1169-1172
[5]   Rational use of new and existing disease-modifying agents in rheumatoid arthritis [J].
Kremer, JM .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :695-706